Main content
Sorry, this episode is not currently available

Drug Prices in Developing Countries

The pharmaceutical industry and the price of drugs in the developing world

GlaxoSmithKline has announced price-cuts for drugs in the developing world. An interview with CEO of the company, Andrew Witty.
Also: Yusuf Hamied, head of generic drugs company Cipla, and Mogha Kamal-Yanni, HIV policy advisor at Oxfam, give their reaction to Andrew Witty's announcement and their opinions on patenting medicines.
HPV vaccination to be provided at cost in Africa by drug company Merck.

Release date:

26 minutes

Podcast